These claimed adverse functions occurred at an incidence of 1% or less. Having said that, available facts are not able to provide a dependable estimate in the incidence, if any, of dependence throughout treatment at suggested doses. Postmarketing experiences of abuse, dependence and withdrawal are already received.Zolpidem, the Lively moiety of zol